Aurobindo Pharma Limited (NSE:AUROPHARMA) — Stock Price

Rs1648.00 INR
▼ -0.60% today

Aurobindo Pharma Limited (NSE:AUROPHARMA) is currently trading at Rs1648.00 INR, down 0.60% today. Over the past 52 weeks, shares have ranged between Rs1022.20 and Rs1658.00. This page tracks Aurobindo Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AUROPHARMA company net worth.

Aurobindo Pharma Limited (AUROPHARMA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Aurobindo Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Aurobindo Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Aurobindo Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs336.53 Billion Rs317.24 Billion Rs290.02 Billion Rs248.55 Billion Rs234.55 Billion
Cost of Revenue Rs204.57 Billion Rs134.84 Billion Rs129.86 Billion Rs116.42 Billion Rs104.50 Billion
Gross Profit Rs131.96 Billion Rs182.40 Billion Rs160.16 Billion Rs132.14 Billion Rs130.06 Billion
Research & Development — Rs16.92 Billion Rs15.22 Billion Rs14.53 Billion Rs16.25 Billion
SG&A — Rs44.76 Billion Rs8.18 Billion Rs6.62 Billion Rs6.80 Billion
Total Operating Expenses Rs81.19 Billion Rs62.39 Billion Rs55.66 Billion Rs51.09 Billion Rs52.00 Billion
Operating Income Rs50.78 Billion Rs120.01 Billion Rs104.50 Billion Rs81.05 Billion Rs78.06 Billion
EBITDA Rs68.56 Billion Rs64.36 Billion Rs57.64 Billion Rs36.34 Billion Rs43.11 Billion
EBIT Rs50.78 Billion Rs49.87 Billion Rs43.92 Billion Rs25.12 Billion Rs33.06 Billion
Interest Expense Rs3.84 Billion Rs4.57 Billion Rs2.90 Billion Rs1.40 Billion Rs486.40 Million
Income Before Tax Rs51.12 Billion Rs50.66 Billion Rs43.80 Billion Rs26.12 Billion Rs33.73 Billion
Income Tax Expense Rs16.09 Billion Rs15.83 Billion Rs12.11 Billion Rs6.85 Billion Rs7.26 Billion
Net Income Rs35.05 Billion Rs34.86 Billion Rs31.73 Billion Rs19.27 Billion Rs26.48 Billion

Aurobindo Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Aurobindo Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs585.02 Billion Rs497.85 Billion Rs450.72 Billion Rs398.90 Billion Rs339.22 Billion
Total Current Assets Rs327.09 Billion Rs271.62 Billion Rs242.06 Billion Rs215.46 Billion Rs181.23 Billion
Cash & Equivalents — Rs29.20 Billion Rs21.11 Billion Rs27.30 Billion Rs6.30 Billion
Short-term Investments Rs7.47 Billion Rs26.32 Billion Rs29.32 Billion Rs18.27 Billion Rs4.04 Billion
Net Receivables Rs71.12 Billion Rs57.61 Billion Rs48.17 Billion Rs44.66 Billion Rs43.87 Billion
Inventory Rs120.53 Billion Rs105.44 Billion Rs98.08 Billion Rs85.11 Billion Rs75.54 Billion
Property, Plant & Equipment — Rs154.55 Billion Rs142.85 Billion Rs124.92 Billion Rs106.66 Billion
Goodwill Rs8.00 Billion Rs6.18 Billion Rs5.95 Billion Rs5.96 Billion Rs4.75 Billion
Total Liabilities Rs206.19 Billion Rs171.38 Billion Rs152.21 Billion Rs130.38 Billion Rs93.48 Billion
Total Current Liabilities Rs180.39 Billion Rs146.82 Billion Rs121.99 Billion Rs114.94 Billion Rs81.56 Billion
Long-term Debt Rs8.03 Billion Rs15.62 Billion Rs21.35 Billion Rs6.19 Billion Rs2.49 Billion
Net Debt Rs-17.97 Billion Rs273.80 Million Rs32.54 Billion Rs8.90 Billion Rs-8.84 Billion
Total Stockholder Equity Rs378.91 Billion Rs326.53 Billion Rs298.43 Billion Rs268.40 Billion Rs245.76 Billion
Retained Earnings — Rs302.22 Billion Rs268.01 Billion Rs240.13 Billion Rs225.19 Billion

Aurobindo Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Aurobindo Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs55.13 Billion Rs39.25 Billion Rs24.35 Billion Rs23.87 Billion Rs50.16 Billion
Capital Expenditures Rs26.86 Billion Rs19.68 Billion Rs35.62 Billion Rs27.20 Billion Rs27.05 Billion
Free Cash Flow Rs28.27 Billion Rs19.57 Billion Rs-11.27 Billion Rs-3.34 Billion Rs23.12 Billion
Investing Cash Flow Rs-37.89 Billion Rs-18.76 Billion Rs-42.56 Billion Rs-39.78 Billion Rs-32.12 Billion
Financing Cash Flow Rs-9.25 Billion Rs1.20 Billion Rs8.00 Billion Rs18.14 Billion Rs-29.69 Billion
Dividends Paid Rs2.32 Billion Rs10.40 Million Rs2.64 Billion Rs4.40 Billion Rs2.64 Billion
Stock-Based Compensation — — Rs89.10 Million Rs-57.50 Million —
Depreciation Rs17.78 Billion Rs16.49 Billion Rs14.92 Billion Rs12.45 Billion Rs11.27 Billion
Change in Cash Rs42.67 Billion Rs21.78 Billion Rs-10.07 Billion Rs2.30 Billion Rs-11.67 Billion

Aurobindo Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Aurobindo Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 21, 2026 15.86 16.31 -2.76%
Feb 09, 2026 16.43 15.89 +3.40%
Nov 05, 2025 14.61 15.24 -4.13%
Aug 04, 2025 14.20 16.49 -13.89%
May 26, 2025 15.56 17.79 -12.54%
Feb 06, 2025 14.56 15.54 -6.31%
Nov 09, 2024 14.00 16.29 -14.06%
Aug 10, 2024 15.69 16.58 -5.37%